NCT05524025View on ClinicalTrials.gov

The SPOT-HPV Study

Active, not recruitingOBSERVATIONAL
Enrollment

360

Participants

Timeline

Start Date

November 30, 2022

Primary Completion Date

September 1, 2024

Study Completion Date

September 1, 2025

Conditions
HPV InfectionHPV Positive Oropharyngeal Squamous Cell Carcinoma
Interventions
DIAGNOSTIC_TEST

Salivary TTMV-HPV DNA Test

Mouthwash rinse

DIAGNOSTIC_TEST

Blood TTMV-HPV DNA Test

Blood test

Trial Locations (2)

02115

Brigham & Woman's Hospital, Boston

Dana Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER